J&J(JNJ)
Search documents
 Wall Street Lunch: Amazon, OpenAI Sign $38B Cloud Deal
 Seeking Alpha· 2025-11-03 18:52
    4kodiak/iStock Unreleased via Getty Images Listen below or on the go on Apple Podcasts and Spotify    OpenAI enters ‘adulthood’ with access to hundreds of thousands of Nvidia GPUs. (0:15) Analyst values Nvidia at $8.5 trillion. (1:05) Kimberly-Clark to buy Tylenol maker Kenvue. (1:29) This is an abridged transcript of the podcast: Our top story so far, OpenAI (OPENAI) announced on Monday that it has signed a deal with Amazon (AMZN) Web Services worth $38 billion to help supply it with "hundreds of thous ...
 The CEO Revolving Door Speeds Up
 Forbes· 2025-11-03 17:12
It’s a difficult time to be in business, and for many companies, the CEO’s position is becoming a revolving door. According to new data from executive search and leadership advisory firm Russell Reynolds Associates shared exclusively with Forbes, 174 global CEOs left their positions just in the quarter. Average CEO tenure declined to 7.2 years in Q3—down more than a year from the average 8.4-year tenure reported just two years ago.Russell Reynolds Associates notes that these results indicate a shift in boar ...
 聚焦进博会|助听眼镜、人工心脏,这些医疗“黑科技”将首次亮相进博会
 Di Yi Cai Jing· 2025-11-03 14:33
根据中国听觉健康管理协会上周发布的《中国老年人听觉健康白皮书(2025)》,中国65岁以上老年人群中,中度及以上 听力损失患病率超33%,据此估算,受影响老年人口已突破1.2亿;而在75岁以上老年人群中,听力损失比例更上升至约 50%,80岁以上则超过三分之二。 数字化、智能化和精准化正在成为医疗器械产品开发的趋势。今年首次亮相进博会的产品包括一款能够"听见"的智能眼 镜,以及马斯克的脑机接口公司临床试验所使用的磁共振设备。 本周,第八届中国国际进口博览会(以下简称"进博会")即将启幕。进博会持续发挥"展品变商品"的加速器作用。 中国作为最大的医疗健康市场之一,在全球医疗创新生态中的地位也日益凸显。大量跨国药械企业通过进博会的平台,将 创新医疗产品和技术加速引进并在中国落地。 数字化、智能化和精准化正在成为医疗器械产品开发的趋势。在今年的进博会上,多个"黑科技"产品将首次亮相,其中包 括一款能够"听见"的智能眼镜,以及科技富豪马斯克旗下脑机接口公司Neuralink临床试验所使用的磁共振设备。 依视路陆逊梯卡集团向第一财经记者介绍称,在今年的进博会上,公司将展出一款融合视听"黑科技"的创新产品—— Nuanc ...
 Kimberly-Clark agrees to buy Tylenol owner Kenvue in $48.7 billion deal, creating consumer staples giant
 CNBC· 2025-11-03 12:56
Kimberly-Clark announced Monday it's struck an agreement to buy Kenvue in a deal valued at $48.7 billion that would create a consumer staples giant.The deal is a combination of cash and stock. Shares of Kenvue surged 20% in premarket trading Monday, while shares of Kimberly-Clark plunged 14%.The combined company would bring together brands like Huggies and Kleenex with the likes of Band-Aid and Tylenol. It would include 10 billion-dollar brands, the companies said in a news release. The acquisition would be ...
 Johnson & Johnson Showcases Latest Advancements in Pulsed Field Ablation with Multiple Clinical and Real-world Studies at APHRS and JPHRS
 The Manila Times· 2025-11-03 06:54
 Key oral presentations highlight new safety, efficacy and workflow improvements data to optimize irrigation and support consistent procedural outcomes.YOKOHAMA, Japan, Nov. 3, 2025 /PRNewswire/ -- Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment1, today announced that new clinical and real-world data from its integrated-by-design VARIPULSE™ Platform in pulsed field ablation (PFA) procedures for atrial fibrillation (AF) will be presented at the Asia Pacific Heart Rhythm Society (AP ...
 Women We Admire Announces Top 50 Women Leaders of New Jersey for 2025
 PRWEB· 2025-11-02 16:30
Women We Admire is pleased to announce The Top 50 Women Leaders of New Jersey for 2025 NEW YORK, Nov. 2, 2025 /PRNewswire-PRWeb/ -- Women We Admire is pleased to announce The Top 50 Women Leaders of New Jersey for 2025. Though small in size, New Jersey's influence is outsized—home to one of the highest concentrations of scientists and engineers per square mile in the U.S. Its economy spans pharmaceuticals, logistics, finance, and beyond, anchored by its strategic location between New York and Philadelphia.  ...
 Jury Awards $20 MILLION in Casaretto v. Johnson & Johnson
 PRWEB· 2025-11-02 02:00
 Core Points - Dr. Casaretto, a long-time medical professional, used Johnson & Johnson's talcum powder daily and later developed malignant mesothelioma, leading to his death in December 2022 [1][2] - His case provides a significant exposure history in talc litigation, with experts finding asbestos in his product despite no known asbestos exposure in his career [2] - Allegations against Johnson & Johnson claim that their talc products, marketed as "gentle" and "safe," were contaminated with asbestos, and the company concealed these risks for decades [3]
 跨国药企三季报密集披露,多家企业上调今年业绩指引
 Bei Ke Cai Jing· 2025-11-01 03:53
 Core Insights - The competition for the title of "King of Drugs" is intensifying, with Eli Lilly's weight loss drug, Tirzepatide, leading sales in the first three quarters of the year, surpassing Merck's Keytruda [2][3] - Major pharmaceutical companies, including Johnson & Johnson, Roche, and Merck, have raised their annual revenue guidance following strong third-quarter performances [5][6][7]   Group 1: Company Performance - Johnson & Johnson reported total revenue of $69.63 billion, leading the industry, with pharmaceutical revenue at $44.64 billion [4] - Eli Lilly achieved pharmaceutical revenue of $45.89 billion, driven by Tirzepatide, which generated $24.8 billion in sales [3][5] - Merck's total revenue reached $48.61 billion, with pharmaceutical revenue at $43.3 billion; however, sales growth for Keytruda has slowed [7]   Group 2: Drug Sales Highlights - Tirzepatide's sales for the first three quarters reached $24.84 billion, with a significant increase in sales for its diabetes version, Mounjaro, which saw a 109% year-on-year growth [3] - Keytruda's sales were $23.30 billion, reflecting an 8% growth, but the growth rate is slowing down [7] - Roche's Phesgo saw a 54% increase in sales, contributing to a pharmaceutical revenue of approximately $42.55 billion [6]   Group 3: Revenue Guidance Adjustments - Eli Lilly raised its full-year revenue guidance to between $63 billion and $63.5 billion [5] - Johnson & Johnson adjusted its revenue forecast to grow by 4.8% to 5.3%, targeting $93 billion to $93.4 billion [5] - Roche also increased its annual revenue expectations based on strong third-quarter results [6]
 The 35 richest families in America, ranked
 Yahoo Finance· 2025-10-31 23:53
 Group 1 - Timothy Mellon anonymously donated $130 million to fund paychecks for US Armed Forces during a government shutdown [1] - Andrew Mellon, a prominent figure from the Gilded Age, served as US Secretary of the Treasury and founded Union Steel and acquired Gulf Oil [2] - The Hughes family's wealth originates from Public Storage Inc., which owns 9% of the self-storage space in the US as of 2023 [3]   Group 2 - The article ranks the 35 richest families in the US based on estimated net worths from Forbes as of February 2024 [4] - Notable families include the Hearsts, Newhouses, Waltons, and Pritzkers, who built wealth through various industries including publishing, retail, and hospitality [5][6]   Group 3 - The Rollins family, through Rollins Inc., owns Orkin, the largest pest control corporation in the US, with the family holding about 40% of the company [7][8] - The Chao family, with a net worth of $14.2 billion, founded Westlake Corporation, a leader in petrochemicals, generating $12.1 billion in revenue in 2024 [9][10]   Group 4 - The Haslam family, with a net worth of $14.4 billion, built wealth through the Pilot Company, which is now fully owned by Berkshire Hathaway [11] - The Crown family, with a net worth of $14.7 billion, has diverse holdings through Henry Crown & Company, including ski resorts and manufacturing firms [13]   Group 5 - The Stryker family, with a net worth of $15.9 billion, owns 11% of Stryker Corporation, which had sales exceeding $20 billion in 2023 [15][16] - The Meijer family operates a grocery store chain with over 500 locations and an estimated annual revenue of $22 billion [18]   Group 6 - The Marriott family, with a net worth of $15.9 billion, owns hotel brands like Sheraton and Ritz-Carlton, with the family holding approximately 16% of the company's shares [20][21] - The Johnson family, with a net worth of $16 billion, has ties to Johnson & Johnson, a global pharmaceutical brand [23][24]   Group 7 - The Kohler family, with a net worth of $16.2 billion, has transitioned from manufacturing farm tools to bathroom fixtures, generating $9 billion in revenue in 2024 [25] - The Brown family, with a net worth of $16.5 billion, owns Brown-Forman Corp., known for brands like Jack Daniel's [27]   Group 8 - The Dorrance family, with a net worth of $17 billion, controls over 50% of Campbell Soup Company, which generates more than $9 billion in annual revenue [29] - The du Pont family, with a net worth of $18.1 billion, has a long-standing fortune from the chemicals giant DuPont, founded in 1802 [30]   Group 9 - The Ziff family, with a net worth of $18.5 billion, grew their wealth through Ziff Davis Inc. and investments via Ziff Brothers Investments [32][34] - The Butt family, with a net worth of $18.8 billion, operates H.E. Butt grocery stores, generating over $46 billion in revenue in 2024 [36]   Group 10 - The Taylor family, with a net worth of $19 billion, controls Enterprise Mobility, which reported $35 billion in revenue in the 2023 fiscal year [38] - The Smith family, with a net worth of $19.8 billion, has significant holdings in Illinois Tool Works and Northern Trust [42]   Group 11 - The Reyes family, with a net worth of $19.9 billion, leads Reyes Holdings, a major food-and-beverage distributor [44] - The Busch family, with a net worth of $20 billion, has historical ties to Anheuser-Busch, which was fully bought out for $52 billion in 2008 [45]   Group 12 - The Hearst family, with a net worth of $22.4 billion, controls Hearst Corporation, a major media conglomerate [47] - The Newhouse family, with a net worth of $24.1 billion, derives wealth from Advance Publications, which owns Condé Nast [49]   Group 13 - The Hunt family, with a net worth of $24.8 billion, built their fortune through Hunt Oil Company and various real estate investments [50] - The Lauder family, with a net worth of $25.9 billion, operates Estée Lauder, generating over $15 billion in revenue in fiscal year 2024 [53]   Group 14 - The Cox family, with a net worth of $26.8 billion, has diversified interests in cable, media, and automotive industries, generating about $20 billion in revenue annually [56] - The Duncan family, with a net worth of $30 billion, controls Enterprise Products Partners, which has seen its fortune more than double since 2010 [57]   Group 15 - The Cathy family, with a net worth of $33.6 billion, operates Chick-fil-A, which remains family-owned and has seen significant growth [59] - The SC Johnson family, with a net worth of $38.5 billion, produces well-known cleaning products and is led by fifth-generation family members [61]   Group 16 - The Pritzker family, with a net worth of $41.6 billion, founded Hyatt Hotels and has been involved in various investments and political activities [63] - The Johnson family, with a net worth of $44.8 billion, controls Fidelity, one of the largest mutual-fund companies, generating over $32 billion in revenue in 2024 [66]   Group 17 - The Cargill-MacMillan family, with a net worth of $60.6 billion, owns 88% of Cargill Inc., which generated over $160 billion in revenue in 2024 [68] - The Koch family, with a net worth of $116 billion, expanded their father's oil-refinery firm into a conglomerate generating roughly $125 billion in annual revenue [70]   Group 18 - The Mars family, with a net worth of $117 billion, operates Mars Inc., which generated over $50 billion in revenue in 2024 [73] - The Walton family, with a net worth of $267 billion, founded Walmart, which reported $648.1 billion in revenue in 2024, making it the largest retailer globally [75]
 Market Rallies as Pfizer Secures Metsera Deal, J&J Expands Drug Application
 Stock Market News· 2025-10-31 20:08
Key TakeawaysMajor U.S. stock indices closed higher, with the Dow Jones up 0.15%, the S&P 500 gaining 0.31%, and the Nasdaq leading the rally with a 0.70% increase.Pfizer (PFE) received early U.S. Federal Trade Commission (FTC) clearance for its Metsera acquisition, a crucial step forward in its strategy to enter the rapidly growing obesity drug market.Johnson & Johnson (JNJ) submitted an application to the U.S. FDA for Stelara® (ustekinumab) for the treatment of pediatric ulcerative colitis, aiming to expa ...